| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 8 |
| 1 | CYCLOPHOSPHAMIDE | 8 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 8 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 8 |
| 4 | ETOPOSIDE | 8 |
| 5 | BUSULFAN | 6 |
| 6 | CARBOPLATIN | 6 |
| 7 | MELPHALAN HYDROCHLORIDE | 6 |
| 8 | MELPHALAN | 5 |
| 9 | ADALIMUMAB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALBENDAZOLE | 3 | 0.0016 |
| 1 | CHOLESTERINUM | 1 | 0.0009 |
| 2 | TRIPTORELIN PAMOATE | 1 | 0.0004 |
| 3 | BUSULFAN | 6 | 0.0004 |
| 4 | DEUCRAVACITINIB | 1 | 0.0003 |
| 5 | DOBUTAMINE | 1 | 0.0003 |
| 6 | MELPHALAN HYDROCHLORIDE | 6 | 0.0002 |
| 7 | PERINDOPRIL ERBUMINE | 1 | 0.0002 |
| 8 | LAMIVUDINE AND ZIDOVUDINE | 1 | 0.0001 |
| 9 | ETOPOSIDE | 8 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 3 | 0.0010 |
| 1 | Tyrosine Kinase 2 Inhibitor [EPC] | 1 | 0.0003 |
| 2 | Topoisomerase Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Gonadotropin Releasing Hormone Receptor Antagonist [EPC] | 1 | 0.0000 |
| 7 | Provitamin D2 Compound [EPC] | 1 | 0.0000 |
| 8 | Alkylating Drug [EPC] | 8 | 0.0000 |
| 9 | Platinum-based Drug [EPC] | 8 | 0.0000 |